ASSESSMENT OF INSULIN PRODUCING FUNCTION OF THE PANCREAS AND THE MARKER OF INSULIN RESISTANCE IN LOW-PROGRESSIVE AUTOIMMUNE DIABETES IN ADULTS (LADA) PATIENTS
Keywords:ow-progressive autoimmune diabetes of adults (Latent autoimmune diabetes of the adults — LADA), C-peptide, insulin resistance
It were examined 262 patients, among which there were 121 patients with low-progressive autoimmune diabetes of adults (LADA), 60 patients with type 1 diabetes mellitus (DM) and 81 patients with diagnosed type 2 DM. It was performed comparative analysis of C-peptide level and indicators of insulin resistance (IR) in patients in the monitoring groups. It was installed the authentic reduction of C-peptide level in the blood of LADA patients and type 1 DM patients compared with type 2 DM patients. It wasn’t established in the absence of significant differences on this index between LADA patients and type 1 DM patients, despite on a significant reduction in C-peptide in patients LADA compared with controls, significant differences in this case. According to the results of calculating several coefficients, that are recommended for the determination of IR, it was confirmed the presence of this state in patients LADA. At the same time indicators of IR in LADA patients were significantly lower than in type 2 DM patients. These data indicate that the disorders of carbohydrate metabolism in LADA patients are caused by the decrease in the insulin secretion in pancreas β-cells, and also by the presence of IR.
Diabetes Care 2002: 21 p.
Pan’kiv VI. Mizhnar Endokrynol Zhurn 2013; 7:95-104.
Tuomi T, Santoro N, Caprio S, et al. Lancet 2014;383(9922):1084- 1094.
Zimmet PZ, Tuomi T, Mackay IR, et al. Diabetic Med 1994; 11:299-303.
Seok H, Lee BW. Diab Metab J 2012; 36(2):116-119.
Li X, Huang G, Yan X, et al. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30(6):1247-1249.
Nikonova TV. Saharnyj diabet 1 tipa i latentnyj autoimmunnyj diabet vzroslyh (LADA): klinicheskie, immuno-geneticheskie i gormonal’nometabolicheskie aspekty, Moskva, 2011: 38 p.
Behme MT, Dupre J, Harris SB, et al. Ann N Y Acad Sci 2003; 1005:374-377.
Salem SD, Saif-Ali R, Muniandy S, et al. Ann Acad Med Singapore 2014; 43(2):107-112.
Djekic K, Mouzeyan A, Ipp E. J Clin Endocrinol Metab 2012; 97(3):E409-413.
Majorov AJu, Urbanova KA, Galstjan GR. Ozhirenie i Metabolizm 2009; 2:19-23.
Ohkura T, Shiochi H, Fujioka Y, et al. Cardiovasc Diabetol 2013; 12:21.
Kawamoto R, Tabara Y, Kohara K, et al. Lipids Health Dis 2011; 10:79.
Bell DS, Ovalle F. Am J Ther 2004; 11(4):308-311.
Li X, Huang G, Lin J, et al. BMC Endocr Dis 2013;1(13): 10.
Borovikov VP. Populjarnoe vvedenie v programmu STATISTICA, Moskva, 1998: 267 p.
Momin AA, Bankar MP, Bhoite GM. IOSR J Pharm 2014; 4(6):9-14.
Barrera JR, Jimeno CA, Paz-Pacheco E. J Diabetes Metab 2013; 4(10):315.